Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 16,343 shares at $102.53 ($1.7M) on 2020-10-16, disclosed to the SEC on 2020-10-20.
Open-market sale of $1.7M BPMC by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.55 | 7,200 | $724K | 43.7% |
| 2 | $101.56 | 3,125 | $317K | 19.1% |
| 3 | $102.53 | 3,009 | $309K | 18.6% |
| 4 | $102.53 | 3,009 | $309K | 18.6% |
| Total | $101.47 avg | 16,343 | $1.7M | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |